David R Stukus1, Nabeel Farooqui2, Kasey Strothman3, Kelsey Ryan4, Songzhu Zhao5, Jack H Stevens6, Daniel M Cohen4. 1. Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio. Electronic address: David.stukus@nationwidechildrens.org. 2. Allergy Partners, Indianapolis, Indiana. 3. Division of Allergy and Immunology, Nationwide Children's Hospital, Columbus, Ohio. 4. Division of Emergency Medicine, Nationwide Children's Hospital, Columbus, Ohio. 5. Center for Biostatistics at The Ohio State University, Nationwide Children's Hospital, Columbus, Ohio. 6. Center for Biobehavioral Health, Nationwide Children's Hospital, Columbus, Ohio.
Abstract
BACKGROUND: Mobile health applications for asthma are increasingly being developed. However, there are no published randomized controlled trials evaluating efficacy in decreasing exacerbations. OBJECTIVE: To evaluate the impact of a mobile asthma application for asthma-related urgent health care usage. METHODS: We conducted a 6-month prospective randomized controlled trial for patients (6 months-21 years old) with persistent asthma presenting with an asthma exacerbation to the emergency department of a pediatric academic medical center. Participants were randomized to AsthmaCare (application providing medication and trigger reminders and treatment plan) or the control (online asthma information). Primary outcome measures were comparison of emergency department and urgent care visits and hospitalizations 6 months before and after randomization. RESULTS: AsthmaCare participants (n = 98) were slightly older (7.84 vs 6.24 years; P = .02) than controls (n = 95) but similar for sex (55% vs 62% boys), race (83% vs 77% African American), and insurer (89% vs 98% Medicaid). The 2 groups were similar in having more than 2 comorbidities (34% vs 32%) and receiving National Heart, Lung, and Blood Institute step 3 treatment or higher (69% vs 57%). There was no significant decrease in emergency department or urgent care visits or hospitalizations between the intervention and control groups. AsthmaCare participants were more likely to report improvement in asthma management 6 months after study enrollment (79% vs 64%; P = .06). CONCLUSION: This randomized controlled trial did not demonstrate a significant decrease in asthma-related emergency department visits or hospitalizations among children who used a mobile health application. TRIAL REGISTRATION: ClinicalTrials.gov, Identifier NCT02333630.
RCT Entities:
BACKGROUND: Mobile health applications for asthma are increasingly being developed. However, there are no published randomized controlled trials evaluating efficacy in decreasing exacerbations. OBJECTIVE: To evaluate the impact of a mobile asthma application for asthma-related urgent health care usage. METHODS: We conducted a 6-month prospective randomized controlled trial for patients (6 months-21 years old) with persistent asthma presenting with an asthma exacerbation to the emergency department of a pediatric academic medical center. Participants were randomized to AsthmaCare (application providing medication and trigger reminders and treatment plan) or the control (online asthma information). Primary outcome measures were comparison of emergency department and urgent care visits and hospitalizations 6 months before and after randomization. RESULTS: AsthmaCare participants (n = 98) were slightly older (7.84 vs 6.24 years; P = .02) than controls (n = 95) but similar for sex (55% vs 62% boys), race (83% vs 77% African American), and insurer (89% vs 98% Medicaid). The 2 groups were similar in having more than 2 comorbidities (34% vs 32%) and receiving National Heart, Lung, and Blood Institute step 3 treatment or higher (69% vs 57%). There was no significant decrease in emergency department or urgent care visits or hospitalizations between the intervention and control groups. AsthmaCare participants were more likely to report improvement in asthma management 6 months after study enrollment (79% vs 64%; P = .06). CONCLUSION: This randomized controlled trial did not demonstrate a significant decrease in asthma-related emergency department visits or hospitalizations among children who used a mobile health application. TRIAL REGISTRATION: ClinicalTrials.gov, Identifier NCT02333630.
Authors: Robert S Rudin; Christopher H Fanta; Nabeel Qureshi; Erin Duffy; Maria O Edelen; Anuj K Dalal; David W Bates Journal: Appl Clin Inform Date: 2019-10-16 Impact factor: 2.342
Authors: Amy Chan; Anna De Simoni; Vari Wileman; Lois Holliday; Chris J Newby; Claudia Chisari; Sana Ali; Natalee Zhu; Prathima Padakanti; Vasita Pinprachanan; Victoria Ting; Chris J Griffiths Journal: Cochrane Database Syst Rev Date: 2022-06-13
Authors: Emily Donovan; Christopher R Wilcox; Sanjay Patel; Alastair D Hay; Paul Little; Merlin L Willcox Journal: Br J Gen Pract Date: 2020-02-27 Impact factor: 5.386
Authors: Tobias Kowatsch; Theresa Schachner; Samira Harperink; Filipe Barata; Ullrich Dittler; Grace Xiao; Catherine Stanger; Florian V Wangenheim; Elgar Fleisch; Helmut Oswald; Alexander Möller Journal: J Med Internet Res Date: 2021-02-17 Impact factor: 5.428